Katharine Knobil's most recent trade in Korro Bio Inc. was a trade of 6,010 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Korro Bio Inc. | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,010 | 6,010 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 30,000 | - | - | Common Stock (Right to Buy) | |
| Marker Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Korro Bio Inc. | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 9,041 | 9,041 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Pliant Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | Katharine Knobil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) |